Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
220
DIFLUPREDNATE
(2008)
Small molecule
Glucocorticoid receptor agonist
OPHTHALMIC
Approved
Inflammation; Uveitis, Anterior
DIFLUPREDNATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
S8A06QG2QE
Molecule Type:
Small molecule
Molecular Formula:
C27H34F2O7
Molecular Weight:
508.56
AlogP:
3.52
PSA:
106.97
HBD:
1.0
HBA:
#RotB:
6.0
Source:
FOSAPREPITANT DIMEGLUMINE
(2008)
Small molecule
Neurokinin 1 receptor antagonist
INJECTION; INTRAVENOUS; UNKNOWN
Approved
Neoplasms; Postoperative Nausea and Vomiting
FOSAPREPITANT DIMEGLUMINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
D35FM8T64X
Molecule Type:
Small molecule
Molecular Formula:
C37H56F7N6O16P
Molecular Weight:
1004.84
AlogP:
4.37
PSA:
129.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FOSAPREPITANT
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSAPREPITANT
×
Maximum Phase:
4
First Approval:
2008
UNII:
6L8OF9XRDC
Molecule Type:
Small molecule
Molecular Formula:
C23H22F7N4O6P
Molecular Weight:
614.41
AlogP:
4.37
PSA:
129.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FOSPROPOFOL
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSPROPOFOL
×
Maximum Phase:
4
First Approval:
2008
UNII:
LZ257RZP7K
Molecule Type:
Small molecule
Molecular Formula:
C13H21O5P
Molecular Weight:
288.28
AlogP:
3.38
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PRASUGREL
(2009)
Small molecule
Unknown
Unknown
Approved
Thrombosis
PRASUGREL
×
Maximum Phase:
4
First Approval:
2009
UNII:
34K66TBT99
Molecule Type:
Small molecule
Molecular Formula:
C20H20FNO3S
Molecular Weight:
373.45
AlogP:
3.89
PSA:
46.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ARTEMETHER
(2009)
Small molecule
Ferriprotoporphyrin IX inhibitor
Unknown
Approved
Malaria
ARTEMETHER
×
Maximum Phase:
4
First Approval:
2009
UNII:
C7D6T3H22J
Molecule Type:
Small molecule
Molecular Formula:
C16H26O5
Molecular Weight:
298.38
AlogP:
2.84
PSA:
46.15
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ESLICARBAZEPINE ACETATE
(2009)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Seizures
ESLICARBAZEPINE ACETATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
BEA68ZVB2K
Molecule Type:
Small molecule
Molecular Formula:
C17H16N2O3
Molecular Weight:
296.33
AlogP:
3.06
PSA:
72.63
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PRASUGREL HYDROCHLORIDE
(2009)
Small molecule
Purinergic receptor P2Y12 antagonist
ORAL
Approved
Acute Coronary Syndrome; Hemorrhage; Myocardial Infarction
PRASUGREL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
G89JQ59I13
Molecule Type:
Small molecule
Molecular Formula:
C20H21ClFNO3S
Molecular Weight:
409.91
AlogP:
3.89
PSA:
46.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ESTRADIOL VALERATE
(2010)
Small molecule
Estrogen receptor alpha agonist
INJECTION
Approved
Atrophy; Hypogonadism; Menopause; Menorrhagia; Primary Ovarian Insufficiency
ESTRADIOL VALERATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
OKG364O896
Molecule Type:
Small molecule
Molecular Formula:
C23H32O3
Molecular Weight:
356.51
AlogP:
5.35
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FINGOLIMOD HYDROCHLORIDE
(2010)
Small molecule
Sphingosine 1-phosphate receptor agonist
ORAL
Approved
Multiple Sclerosis
FINGOLIMOD HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2010
UNII:
G926EC510T
Molecule Type:
Small molecule
Molecular Formula:
C19H34ClNO2
Molecular Weight:
343.94
AlogP:
3.2
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
12.0
Source:
CEFTAROLINE FOSAMIL
(2010)
Small molecule
Unknown
INTRAVENOUS
Approved
Bacterial Infections
CEFTAROLINE FOSAMIL
×
Maximum Phase:
4
First Approval:
2010
UNII:
7P6FQA5D21
Molecule Type:
Small molecule
Molecular Formula:
C22H21N8O8PS4
Molecular Weight:
684.7
AlogP:
-0.11
PSA:
223.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
FINGOLIMOD
(2010)
Small molecule
Unknown
ORAL
Approved
Immune System Diseases
FINGOLIMOD
×
Maximum Phase:
4
First Approval:
2010
UNII:
3QN8BYN5QF
Molecule Type:
Small molecule
Molecular Formula:
C19H33NO2
Molecular Weight:
307.48
AlogP:
3.2
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
12.0
Source:
DABIGATRAN ETEXILATE
(2010)
Small molecule
Unknown
ORAL
Approved
Thrombosis
DABIGATRAN ETEXILATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
2E18WX195X
Molecule Type:
Small molecule
Molecular Formula:
C34H41N7O5
Molecular Weight:
627.75
AlogP:
5.6
PSA:
154.03
HBD:
2.0
HBA:
#RotB:
15.0
Source:
GABAPENTIN ENACARBIL
(2011)
Small molecule
Voltage-gated calcium channel modulator
ORAL
Approved
Epilepsy; Neuralgia, Postherpetic; Restless Legs Syndrome
GABAPENTIN ENACARBIL
×
Maximum Phase:
4
First Approval:
2011
UNII:
75OCL1SPBQ
Molecule Type:
Small molecule
Molecular Formula:
C16H27NO6
Molecular Weight:
329.39
AlogP:
2.68
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AZILSARTAN KAMEDOXOMIL
(2011)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Hypertension; Stroke
AZILSARTAN KAMEDOXOMIL
×
Maximum Phase:
4
First Approval:
2011
UNII:
WEC6I2K1FC
Molecule Type:
Small molecule
Molecular Formula:
C30H23KN4O8
Molecular Weight:
606.63
AlogP:
4.71
PSA:
155.59
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AZILSARTAN MEDOXOMIL
(2011)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
AZILSARTAN MEDOXOMIL
×
Maximum Phase:
4
First Approval:
2011
UNII:
LL0G25K7I2
Molecule Type:
Small molecule
Molecular Formula:
C30H24N4O8
Molecular Weight:
568.54
AlogP:
4.71
PSA:
155.59
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ABIRATERONE ACETATE
(2011)
Small molecule
Cytochrome P450 17A1 inhibitor
ORAL
Approved
Neoplasms; Prostatic Neoplasms
ABIRATERONE ACETATE
×
Maximum Phase:
4
First Approval:
2011
UNII:
EM5OCB9YJ6
Molecule Type:
Small molecule
Molecular Formula:
C26H33NO2
Molecular Weight:
391.56
AlogP:
5.97
PSA:
39.19
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TAFLUPROST
(2012)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
TAFLUPROST
×
Maximum Phase:
4
First Approval:
2012
UNII:
1O6WQ6T7G3
Molecule Type:
Small molecule
Molecular Formula:
C25H34F2O5
Molecular Weight:
452.54
AlogP:
4.68
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
12.0
Source:
GLYCEROL PHENYLBUTYRATE
(2013)
Small molecule
Glutamine sequestering agent
ORAL
Approved
Urea Cycle Disorders, Inborn
GLYCEROL PHENYLBUTYRATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
ZH6F1VCV7B
Molecule Type:
Small molecule
Molecular Formula:
C33H38O6
Molecular Weight:
530.66
AlogP:
6.05
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
17.0
Source:
ESOMEPRAZOLE STRONTIUM
(2013)
Small molecule
Potassium-transporting ATPase inhibitor
ORAL
Approved
Duodenal Ulcer; Gastroesophageal Reflux; Stomach Ulcer; Zollinger-Ellison Syndrome
ESOMEPRAZOLE STRONTIUM
×
Maximum Phase:
4
First Approval:
2013
UNII:
C5N25H3803
Molecule Type:
Small molecule
Molecular Formula:
C34H44N6O10S2Sr
Molecular Weight:
848.51
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TESTOSTERONE UNDECANOATE
(2014)
Small molecule
Androgen Receptor agonist
INTRAMUSCULAR; ORAL
Approved
Hypogonadism; Klinefelter Syndrome; Neoplasms; Orchitis
TESTOSTERONE UNDECANOATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
H16A5VCT9C
Molecule Type:
Small molecule
Molecular Formula:
C30H48O3
Molecular Weight:
456.71
AlogP:
7.96
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
10.0
Source:
PERINDOPRIL ARGININE
(2015)
Small molecule
Angiotensin-converting enzyme inhibitor
Unknown
Approved
Coronary Artery Disease; Hypertension; Myocardial Infarction
PERINDOPRIL ARGININE
×
Maximum Phase:
4
First Approval:
2015
UNII:
TFT5IM1KGB
Molecule Type:
Small molecule
Molecular Formula:
C25H46N6O7
Molecular Weight:
542.68
AlogP:
1.94
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TENOFOVIR ALAFENAMIDE FUMARATE
(2015)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Hepatitis B, Chronic
TENOFOVIR ALAFENAMIDE FUMARATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
FWF6Q91TZO
Molecule Type:
Small molecule
Molecular Formula:
C46H62N12O14P2
Molecular Weight:
1069.02
AlogP:
2.97
PSA:
143.48
HBD:
2.0
HBA:
#RotB:
11.0
Source:
TENOFOVIR ALAFENAMIDE
(2015)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Approved
Virus Diseases
TENOFOVIR ALAFENAMIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
J4414G3BUK
Molecule Type:
Small molecule
Molecular Formula:
C21H29N6O5P
Molecular Weight:
476.47
AlogP:
2.97
PSA:
143.48
HBD:
2.0
HBA:
#RotB:
11.0
Source:
ARIPIPRAZOLE LAUROXIL
(2015)
Small molecule
Dopamine D2 receptor partial agonist
INTRAMUSCULAR
Approved
Autistic Disorder; Bipolar Disorder; Depressive Disorder, Major; Schizophrenia; Tourette Syndrome
ARIPIPRAZOLE LAUROXIL
×
Maximum Phase:
4
First Approval:
2015
UNII:
B786J7A343
Molecule Type:
Small molecule
Molecular Formula:
C36H51Cl2N3O4
Molecular Weight:
660.73
AlogP:
8.68
PSA:
62.32
HBD:
0.0
HBA:
#RotB:
19.0
Source:
IXAZOMIB CITRATE
(2015)
Small molecule
26S proteosome inhibitor
ORAL
Approved
Multiple Myeloma; Neoplasms
IXAZOMIB CITRATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
46CWK97Z3K
Molecule Type:
Small molecule
Molecular Formula:
C20H23BCl2N2O9
Molecular Weight:
517.13
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DEFLAZACORT
(2017)
Small molecule
Glucocorticoid receptor agonist
ORAL
Approved
Muscular Dystrophies; Muscular Dystrophy, Duchenne
DEFLAZACORT
×
Maximum Phase:
4
First Approval:
2017
UNII:
KR5YZ6AE4B
Molecule Type:
Small molecule
Molecular Formula:
C25H31NO6
Molecular Weight:
441.52
AlogP:
2.56
PSA:
102.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TELOTRISTAT ETHYL
(2017)
Small molecule
Tryptophan 5-hydroxylase inhibitor
Unknown
Approved
Unknown
TELOTRISTAT ETHYL
×
Maximum Phase:
4
First Approval:
2017
UNII:
8G388563M7
Molecule Type:
Small molecule
Molecular Formula:
C27H26ClF3N6O3
Molecular Weight:
574.99
AlogP:
4.99
PSA:
131.17
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BALOXAVIR MARBOXIL
(2018)
Small molecule
Polymerase acidic protein inhibitor
ORAL
Approved
Influenza, Human; Virus Diseases
BALOXAVIR MARBOXIL
×
Maximum Phase:
4
First Approval:
2018
UNII:
505CXM6OHG
Molecule Type:
Small molecule
Molecular Formula:
C27H23F2N3O7S
Molecular Weight:
571.56
AlogP:
3.39
PSA:
99.54
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FOSNETUPITANT
(2018)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSNETUPITANT
×
Maximum Phase:
4
First Approval:
2018
UNII:
T672P80L2S
Molecule Type:
Small molecule
Molecular Formula:
C31H35F6N4O5P
Molecular Weight:
688.61
AlogP:
5.74
PSA:
106.03
HBD:
1.0
HBA:
#RotB:
8.0
Source:
FOSTAMATINIB
(2018)
Small molecule
Tyrosine-protein kinase SYK inhibitor
Unknown
Approved
Hemorrhage
FOSTAMATINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
SQ8A3S5101
Molecule Type:
Small molecule
Molecular Formula:
C23H26FN6O9P
Molecular Weight:
580.47
AlogP:
3.09
PSA:
186.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
FOSTAMATINIB DISODIUM
(2018)
Small molecule
Tyrosine-protein kinase SYK inhibitor
ORAL
Approved
Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
FOSTAMATINIB DISODIUM
×
Maximum Phase:
4
First Approval:
2018
UNII:
86EEZ49YVB
Molecule Type:
Small molecule
Molecular Formula:
C23H36FN6Na2O15P
Molecular Weight:
732.52
AlogP:
3.09
PSA:
186.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
REMDESIVIR
(2020)
Small molecule
RNA-directed RNA polymerase L inhibitor
Unknown
Approved
Severe Acute Respiratory Syndrome; Virus Diseases
REMDESIVIR
×
Maximum Phase:
4
First Approval:
2020
UNII:
3QKI37EEHE
Molecule Type:
Small molecule
Molecular Formula:
C27H35N6O8P
Molecular Weight:
602.59
AlogP:
2.31
PSA:
203.55
HBD:
4.0
HBA:
#RotB:
13.0
Source:
ARTESUNATE
(2020)
Small molecule
Unknown
Unknown
Approved
Malaria
ARTESUNATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
60W3249T9M
Molecule Type:
Small molecule
Molecular Formula:
C19H28O8
Molecular Weight:
384.43
AlogP:
2.6
PSA:
100.52
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GALIDESIVIR
(1)
Small molecule
Genome polyprotein inhibitor
Unknown
Investigational
Unknown
GALIDESIVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
OLF97F86A7
Molecule Type:
Small molecule
Molecular Formula:
C11H15N5O3
Molecular Weight:
265.27
AlogP:
-1.73
PSA:
140.31
HBD:
6.0
HBA:
#RotB:
2.0
Source:
AV-101
(2)
Small molecule
Glutamate [NMDA] receptor antagonist
Unknown
Investigational
Unknown
AV-101
×
Maximum Phase:
2
First Approval:
None
UNII:
77XLH9L40B
Molecule Type:
Small molecule
Molecular Formula:
C10H11ClN2O3
Molecular Weight:
242.66
AlogP:
0.91
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
1
2
…
4
5
6
7
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA